TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Percentage Change in CXCL10
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Psychological Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Number of subjects experiencing serious device-related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects weaned at 48 hours and 120 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini-Mental State Examination for Children (MMC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: plasma concentration of rivaroxaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychosocial Expectancies
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in the intensity of pain in the cervical spine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of MRI sequences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Pain in the knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cochlear Implant Quality of Life (CIQOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Client Orientated Scale of Improvement (COSI)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: AZBio Sentence Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Obstetric Quality of Recovery Score (ObsQoR-10)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Proportion of patients without early success of non-invasive ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Model for End-Stage Liver Disease (MELD) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiovascular and all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Absolute change in the proportion of stools with abnormal fecal consistency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Absolute change in the pain severity score (IBS-SSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variation of OHAT score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Maximum observed plasma concentration (Cmax) of Famitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC0-t) of Famitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the plasma concentration versus time curve (AUC0-∞) of Famitinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spatial synaptic density alterations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Proportion of patients successfully eradicating PA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in Interleukin (IL)-1Ra concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Interleukin (IL)-6 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Interleukin (IL)-10 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Tumor Necrosis Factor (TNF)-a concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: C0/D values of tacrolimus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parent-child communication skills
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Parent-child communication quality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Internet addiction among adolescents
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Dysphagia Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Continuous 4-week nicotine vaping abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numeric Rating Scale (NRS) Change
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Safety of bevacizumab in combination therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Acceptability of the mHealth App Usability Questionnaire (MAUQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Implementation (App usage frequency)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postural Alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trunk Endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with dose limiting toxicities (DLTs) from IMT-009 monotherapy
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with adverse events following administration of IMT-009
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Response Rate (ORR) based on RECIST 1.1 or Lugano criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants with Mild to Moderate Influenza Disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Rate of perianal Crohn's disease relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Degree of Catheter-related Bladder Discomfort
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: burden of caring
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Right ventricular-arterial coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of tinnitus patients who decide to enroll in a clinical study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of tinnitus patients who remain in a clinical study to completion
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Natural history of disease in patients with CKD/ESKD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and effectiveness of CKD/ESKD treatments
Endpoint domain: Adverse events/effects
Primary endpoint: Mimic muscles tone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mimic muscles stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Mimic muscles elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change From Baseline in GOOD ON time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic characteristics of rotator cuff muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Falls prevalence
Endpoint domain: Adverse events/effects
Primary endpoint: Pain (Visual Analogic Scale)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in pressure injury wound area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Functional disability during daily life activities
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Electroencephalographic patterns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: comparison of vestibular depth preoperatively and postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inflammation score scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Body Posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute change in glycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in coupling strength between prefrontal and posterior cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Accuracy of Catheter Localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: surgical complications rate
Endpoint domain: Adverse events/effects
Primary endpoint: efficacy of breast reconstruction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance Visual Acuity (VA) with study lenses at Day 30
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients developing cardiovascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients developing in-hospital mortality
Endpoint domain: Mortality/survival
Primary endpoint: Rate of cardiac dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Density of Neuro-Angiogenesis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Density of Pain Mediators in Pelvic Peritoneum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: European Quality of Life-5 Dimensions Questionnaire (EQ5D) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Healing time of the wound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of recovery 24 hours after surgery
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Psychological Assessment (depression1)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological Assessment (depression2)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological Assessment (Anxiety)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Metabolic Syndrome Components (Waist circumference)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic Syndrome Components (Medical Assessments/ Laboratory Tests)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic Syndrome Components (Medical Assessments/ Blood Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MS QOL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Self Reported Pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Discharge to hospice care
Endpoint domain: Mortality/survival
Primary endpoint: Qualitative fat fraction in lower back and legs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reliability of a new screening tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Validity of a new screening tool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Childhood Autism Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Infants with Major Congenital Malformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Rate of incisional hernias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Rate of complete pathological response (pCR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OMERACT-OARSI response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of tumour response
Endpoint domain: Mortality/survival
Primary endpoint: Occurrence of gastrointestinal toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrence of hand-foot syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Numerical Rating Scale (NPRS-11)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global Rating of Change scale (Patient Satisfaction)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Central Sensitization Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differentiation of gastric disease states
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from Baseline in the Lipid Profile at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in the Blood Pressure at Week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change from Baseline in the Satisfaction with Life at Week 16
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Safety of Allocetra-OTS
Endpoint domain: Adverse events/effects
Primary endpoint: Best Corrected Near Visual Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Habitual Sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate + Variability (HRV) Monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neuropsychological Outcome 1 - ANAM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Prosthetic Function and Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Comfort measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence rate of malocclusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measurement and detection of acetabulum cup retroversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Arrythmia free health status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Body (leg) composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Direct medical costs of diagnostic tools
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Direct medical costs of laboratory tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Direct medical costs of referrals to specialists
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Burden of high-grade gliomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Key molecular features of high-grade gliomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Attitude Towards Repentant Terrorists and their Reintegration Scale
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: brief Verona Service Satisfaction Scale
Endpoint domain: Resource use
Endpoint subdomain: Delivery of care
Primary endpoint: 2-hour blood glucose incremental AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-hour blood insulin incremental AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of lower limb complications
Endpoint domain: Adverse events/effects
Primary endpoint: Longitudinal evolution of biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Psychological Distress Levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: International Survey of Physical Activity (IPAQ)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Goal orientation in exercise measure (GOEM)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: The Problem Areas in Diabetes Scale (PADS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PrEP Measurement Preferences Scale Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants on PrEP who remain engaged in sexual health care
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Share of discharge opioid prescriptions above prescribing guidelines
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Non-sentinel lymph node metastatic status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Device-related or procedure-related major adverse events (MAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Determination of joint Line according to adductor ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Early reading skills
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of responding patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects who developed Retinopathy of Prematurity (ROP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmic outcomes
Primary endpoint: Number of subjects who developed jaundice
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of jaundice (days)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal change in stroke volume index during RIC procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal change in cardiac index during RIC procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Maximal change in peripheral perfusion index during RIC procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hiatal hernia recurrence rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical improvement measured by change in Constant Shoulder Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aggression levels as measured by the Proactive and Reactive Aggression Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: PiCSO device or procedure related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Difference in myocardial infarct size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Disease-free survival after 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Patient's engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Therapist's engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Patient's fingers and wrist movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of reduction in hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of subjects who achieved EASI-75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of subjects with IGA score decrease of ≥ 2 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: s100B levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stopping the progression of the disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: satisfactory re-pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NT-proBNP Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Objective sleep parameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck pain disability index (NDI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: GAD-7 Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Depression Questionnaire (PHQ-9)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of Completed Versus Requested Patient-Generated Data
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Gait Ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall Efficacy
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Concentration changes of small molecules in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: splanchnic oxygenation (rSO2S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetic analysis based on PET scan data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients who died during hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: Difference in soundwaves on the Actuator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self-care practices
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Global rating scale score for fiberoptic intubation performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Secondary attack of antepartum haemorrhage
Endpoint domain: Mortality/survival